We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Donepezil as a safe alternative treatment after maculo‐papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.
- Authors
Chouchana, Margot; Pinel, Sylvine; Colboc, Hester; Soria, Angele; Buard, Geraldine; Delage, Clément; Bloch, Vanessa; Lilamand, Matthieu
- Abstract
The article describes the case of a 79-year old Caucasian man who was treated with donepezil after developing a pruritic erythematous maculopapular eruption at the application site of rivastigmine transdermal patches, which was used to treat his Lewy body disease. The patient's skin lesions did not regress after antihistaminic treatment with cetirizine. A Naranjo scale assessment showed the high probability of the relation of cutaneous adverse effects with rivastigmine transdermal patches.
- Subjects
RIVASTIGMINE; DONEPEZIL; PHARMACOLOGY; LEWY body dementia; PATIENT safety; CHOLINESTERASE inhibitors; HYPERLIPIDEMIA; HYPERTENSION; DRUG eruptions; DIABETES
- Publication
Psychogeriatrics, 2024, Vol 24, Issue 5, p1180
- ISSN
1346-3500
- Publication type
Case Study
- DOI
10.1111/psyg.13166